Shares of Hemispherx BioPharma (NYSEAMERICAN:HEB) are above their 200-day moving average of $0.00

Shares of Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Your Free Report ) broke above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $0.32. Hemispherx BioPharma shares last traded at $0.27 with a volume of 1,527,490 shares.

Hemispherx BioPharma trading down 8.2%

Hemispherx BioPharma Company Profile

(Get a free report)

Hemispherx Biopharma, Inc, a specialty pharmaceutical company, is engaged in the clinical development of drug therapies based on natural immune-enhancing technologies for the treatment of chronic viral and immune diseases in the United States. The company’s products include Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of a class of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).

Featured stories

Get news and reviews for Hemispherx BioPharma Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Hemispherx BioPharma and related companies with MarketBeat.com ‘s FREE daily email newsletter.